Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.
Rowe DT, Webber S, Schauer EM, Reyes J, Green M. Rowe DT, et al. Transpl Infect Dis. 2001 Jun;3(2):79-87. doi: 10.1034/j.1399-3062.2001.003002079.x. Transpl Infect Dis. 2001. PMID: 11395973 Review.
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder.
Cacciarelli TV, Reyes J, Mazariegos GV, Sigurdsson L, Rowe DT, Fung JJ, Green M. Cacciarelli TV, et al. Among authors: rowe dt. Transplant Proc. 1999 Feb-Mar;31(1-2):488-9. doi: 10.1016/s0041-1345(98)01722-9. Transplant Proc. 1999. PMID: 10083204 No abstract available.
Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.
Green M, Cacciarelli TV, Mazariegos GV, Sigurdsson L, Qu L, Rowe DT, Reyes J. Green M, et al. Among authors: rowe dt. Transplantation. 1998 Dec 27;66(12):1641-4. doi: 10.1097/00007890-199812270-00012. Transplantation. 1998. PMID: 9884252
Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.
Panousis CG, Rowe DT. Panousis CG, et al. Among authors: rowe dt. J Virol. 1997 Jun;71(6):4752-60. doi: 10.1128/JVI.71.6.4752-4760.1997. J Virol. 1997. PMID: 9151869 Free PMC article.
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.
Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M. Rowe DT, et al. J Clin Microbiol. 1997 Jun;35(6):1612-5. doi: 10.1128/JCM.35.6.1612-1615.1997. J Clin Microbiol. 1997. PMID: 9163497 Free PMC article.
Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors.
Qu L, Triulzi DJ, Rowe DT, Jenkins FJ. Qu L, et al. Among authors: rowe dt. Vox Sang. 2011 Apr;100(3):267-71. doi: 10.1111/j.1423-0410.2010.01404.x. Epub 2010 Sep 2. Vox Sang. 2011. PMID: 20825598
Stability of lymphocytes and Epstein-Barr virus during red blood cell storage.
Qu L, Triulzi DJ, Rowe DT, Griffin DL, Donnenberg AD. Qu L, et al. Among authors: rowe dt. Vox Sang. 2007 Feb;92(2):125-9. doi: 10.1111/j.1423-0410.2006.00880.x. Vox Sang. 2007. PMID: 17298574
Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children.
Bingler MA, Feingold B, Miller SA, Quivers E, Michaels MG, Green M, Wadowsky RM, Rowe DT, Webber SA. Bingler MA, et al. Among authors: rowe dt. Am J Transplant. 2008 Feb;8(2):442-5. doi: 10.1111/j.1600-6143.2007.02080.x. Am J Transplant. 2008. PMID: 18211510 Free article.
Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.
Miller G, Grogan E, Rowe D, Rooney C, Heston L, Eastman R, Andiman W, Niederman J, Lenoir G, Henle W, et al. Miller G, et al. J Infect Dis. 1987 Jul;156(1):26-35. doi: 10.1093/infdis/156.1.26. J Infect Dis. 1987. PMID: 3036961
CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Green M, Michaels MG, Katz BZ, Burroughs M, Gerber D, Shneider BL, Newell K, Rowe D, Reyes J. Green M, et al. Am J Transplant. 2006 Aug;6(8):1906-12. doi: 10.1111/j.1600-6143.2006.01394.x. Am J Transplant. 2006. PMID: 16889546 Clinical Trial.
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback